The "Pacemakers Market Size, Share & Trends Analysis Report by Product (Implantable, External), by Type (Conventional, MRI Compatible), by Application (Arrhythmias, Congestive Heart Failure), by End-use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global pacemakers market size is anticipated to reach USD 5.94 billion by 2030. The market is expected to expand at a lucrative CAGR of 3.4% from 2022 to 2030.
This growth is owing to various factors such as technological advancements and the increasing prevalence of cardiovascular devices. Furthermore, the growing sedentary lifestyle coupled with the rising geriatric population is also anticipated to fuel the market growth during the projected period. During the COVID-19 pandemic, the market experienced a decline in revenues. This is owing to the postponement and cancellation of surgeries. According to the National Center for Biotechnology Information (NCBI), there was around a 73% reduction in de-novo pacemaker implantation during the initial months of the pandemic, which heavily impacted the market.
The increasing prevalence of cardiovascular diseases is a key growth driver for the market. As per the CDC in 2017, CVDs account for about 800,000 deaths in the U.S alone. Moreover, coronary heart disease accounts for the highest number of deaths, followed by stroke and heart failure. As per the British Heart Foundation Centre in 2018, nearly 7.4 million individuals are living with circulatory and heart diseases in the U.K. More than 43,000 individuals under 75 years of age die due to cardiac diseases every year in the U.K. To curb the rising prevalence of CVDs is government bodies and key market players are channelizing revenues to offer a potential treatment. This is anticipated by the influx of advanced products in this market space.
As per the CDC, 2020, more than 15% of U.S. adults are physically inactive that shows the prevalence of adult physical inactivity. Technological developments are quickly renovating the pacemaker market.
Report Highlights
- The market was valued at USD 4.38 billion in 2021 and is expected to witness a CAGR of 3.4% during the forecast period
- The MRI compatible pacemakers segment is expected to witness the highest CAGR from 2022 to 2030 owing to a higher patient preference rate as 75% of the patients with pacemakers are likely to get MRI during their lifetimes
- The atrial fibrillation segment held the largest revenue share in 2021 owing to the heightened prevalence of growing with age. As per the National Center for Biotechnology Information, 2020, nearly 6 to 12 million people globally are expected to suffer from atrial fibrillation in the US alone by 2050
- The biventricular pacemakers segment is expected to grow fast from 2022 to 2030. It is also known as Cardiac Resynchronization Therapy (CRT). An increase in the prevalence of heart failure is one of the major factors driving the demand for biventricular pacemakers
- Key companies are adopting new strategies to attain a competitive edge. Product development, collaborations, partnerships, mergers and acquisitions, and regional expansion are a few of them
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Pacemaker Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Pacemaker Market Dynamics
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rising prevalence of cardiovascular diseases (CVD)
3.4.1.2 Favorable reimbursement policies
3.4.1.3 Technological advancements
3.4.2 Market Restraint Analysis
3.5 Pacemaker: Market Analysis Tools
3.6 Regulatory Framework
Chapter 4 Competitive & Vendor Landscape
4.1 Participation Categorization
4.2 Public Companies
4.3 Detailed List of Market Players
Chapter 5 Nebulizer Market: Covid-19 Impact Analysis
5.1 Current And Future Impact Analysis
5.2 Covid-19 Opportunity Analysis
Chapter 6 Pacemaker Market: Segment Analysis, By Product, 2017-2030 (USD Million)
6.1 Product Market Share Analysis, 2021 & 2030
6.2 Global Pacemaker Market, by Product, 2017 to 2030
Chapter 7 Pacemaker Market: Segment Analysis, By Type, 2017-2030 (USD Million)
Chapter 8 Pacemaker Market: Segment Analysis, By Application, 2017-2030 (USD Million)
Chapter 9 Pacemaker Market: Segment Analysis, By End Use, 2017-2030 (USD Million)
Chapter 10 Pacemaker Market: Regional Estimates & Trend Analysis, By Product, Type, Application, End Use 2017-2030 (USD Million)
Chapter 11 Company Profile
- Osypka Medical GmbH
- Boston Scientific Corporation
- Zoll Medical Corporation
- Medtronic
- BIOTRONIK
- MicroPort Scientific Corporation
- Cook Medical
- MEDICO SpA
- Pacetronix
- Oscor Inc.
For more information about this report visit https://www.researchandmarkets.com/r/1x2xiu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220128005172/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
